pyrrolidine dithiocarbamate has been researched along with Peritoneal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, HY; Duan, YY; Ji, XQ; Qin, DY; Xu, ZM; Zhang, CM; Zhang, JJ | 1 |
| Aydin, C; Aytekin, FO; Kabay, B; Sacar, S; Simsek, NG; Teke, Z; Tekin, K; Yenisey, C | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and Peritoneal Diseases
| Article | Year |
|---|---|
Application of the nuclear factor-κB inhibitor pyrrolidine dithiocarbamate for the treatment of endometriosis: an in vitro study.
Topics: Antioxidants; Case-Control Studies; Cells, Cultured; Drug Evaluation, Preclinical; Endometriosis; Female; Gene Expression; Humans; Hyaluronan Receptors; Matrix Metalloproteinase 9; NF-kappa B; Ovarian Cysts; Peritoneal Diseases; Pyrrolidines; Stromal Cells; Thiocarbamates; Tissue Inhibitor of Metalloproteinase-1 | 2010 |
Effects of pyrrolidine dithiocarbamate on healing of colonic anastomoses in the cecal ligation and puncture model of intraperitoneal sepsis in rats.
Topics: Anastomosis, Surgical; Animals; Antioxidants; Cecum; Disease Models, Animal; Glutathione; Ligation; Lipid Peroxidation; Male; Peritoneal Diseases; Punctures; Pyrrolidines; Rats; Rats, Wistar; Sepsis; Thiocarbamates; Wound Healing | 2007 |